oxybutynin has been researched along with Adenoma, Prostatic in 7 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the anticholinergic dosage was low, the present results suggest that naftopidil monotherapy was as useful as combination therapy of naftopidil and an anticholinergic agent." | 6.72 | Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study. ( Hanazawa, K; Honda, S; Kawachi, Y; Koizumi, K; Maruyama, O; Noto, K; Saitoh, T; Sugimura, S; Sugiyama, Y; Yamashita, R, 2006) |
| "To evaluate the symptomatic and urodynamic effects of oxybutynin in the control of irritative micturitional symptoms during the first week after transurethral resection of benign prostatic hyperplasia (BPH)." | 5.08 | Oxybutynin in the treatment of early detrusor instability after transurethral resection of the prostate. ( Borst, F; Graber, P; Iselin, CE; Rohner, S; Schmidlin, F, 1997) |
| "2%) reported no treatment-related adverse events; two men (0." | 2.73 | Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions. ( Dahl, NV; Polishuk, PV; Rosenberg, MT; Staskin, DR; Zinner, NR, 2008) |
| "Although the anticholinergic dosage was low, the present results suggest that naftopidil monotherapy was as useful as combination therapy of naftopidil and an anticholinergic agent." | 2.72 | Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study. ( Hanazawa, K; Honda, S; Kawachi, Y; Koizumi, K; Maruyama, O; Noto, K; Saitoh, T; Sugimura, S; Sugiyama, Y; Yamashita, R, 2006) |
| "Whether incontinence after surgery for benign prostatic hypertrophy (BPH) requires simple workup and treatment or being a more complex condition and multifactorial in etiology requiring combined surgical techniques should be investigated in more detail." | 1.30 | Incontinence after surgery for benign prostatic hypertrophy: the case for complex approach and treatment. ( Floratos, D; Katsifotis, C; Mertziotis, N; Moutzouris, G; Plastiras, D; Theodorou, C, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Shah, AA | 1 |
| Kumar, P | 1 |
| Ogunmola, AG | 1 |
| Ayyash, O | 1 |
| Yabes, JG | 1 |
| Sabik, LM | 1 |
| Odisho, AY | 1 |
| Bandari, J | 1 |
| Macleod, LC | 1 |
| Davies, BJ | 1 |
| Jacobs, BL | 1 |
| Hakimi, Z | 1 |
| Johnson, M | 1 |
| Nazir, J | 1 |
| Blak, B | 1 |
| Odeyemi, IA | 1 |
| Barkin, J | 1 |
| Diles, D | 1 |
| Franks, B | 1 |
| Berner, T | 1 |
| Maruyama, O | 1 |
| Kawachi, Y | 1 |
| Hanazawa, K | 1 |
| Koizumi, K | 1 |
| Yamashita, R | 1 |
| Sugimura, S | 1 |
| Honda, S | 1 |
| Sugiyama, Y | 1 |
| Saitoh, T | 1 |
| Noto, K | 1 |
| Staskin, DR | 1 |
| Rosenberg, MT | 1 |
| Dahl, NV | 1 |
| Polishuk, PV | 1 |
| Zinner, NR | 1 |
| Iselin, CE | 1 |
| Schmidlin, F | 1 |
| Borst, F | 1 |
| Rohner, S | 1 |
| Graber, P | 1 |
| Theodorou, C | 1 |
| Moutzouris, G | 1 |
| Floratos, D | 1 |
| Plastiras, D | 1 |
| Katsifotis, C | 1 |
| Mertziotis, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial[NCT03314025] | Phase 2 | 158 participants (Anticipated) | Interventional | 2017-10-06 | Recruiting | ||
| Multicenter Assessment of Transdermal Therapy in Overactive Bladder With Oxybutynin TDS (MATRIX)[NCT00224146] | Phase 4 | 2,878 participants (Actual) | Interventional | 2004-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for oxybutynin and Adenoma, Prostatic
| Article | Year |
|---|---|
Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study.
Topics: Adrenergic alpha-Antagonists; Aged; Benzilates; Cholinergic Antagonists; Drug Therapy, Combination; | 2006 |
Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions.
Topics: Administration, Cutaneous; Adult; Aged; Health Status Indicators; Humans; Male; Mandelic Acids; Midd | 2008 |
Oxybutynin in the treatment of early detrusor instability after transurethral resection of the prostate.
Topics: Aged; Double-Blind Method; Humans; Male; Mandelic Acids; Middle Aged; Parasympatholytics; Postoperat | 1997 |
4 other studies available for oxybutynin and Adenoma, Prostatic
| Article | Year |
|---|---|
Statewide Price Variation for Generic Benign Prostatic Hyperplasia Medications.
Topics: Costs and Cost Analysis; Drugs, Generic; Finasteride; Humans; Male; Mandelic Acids; Pennsylvania; Pr | 2021 |
Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Family Practice; Human | 2015 |
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug | 2015 |
Incontinence after surgery for benign prostatic hypertrophy: the case for complex approach and treatment.
Topics: Aged; Aged, 80 and over; Follow-Up Studies; Humans; Incidence; Male; Mandelic Acids; Middle Aged; Pr | 1998 |